Arcus Biosciences RCUS Interest coverage
Interest coverage at other companies
Other financials
Where this comes from
Calculated from Arcus Biosciences’s reported figures.
Based on trailing twelve months.
The official record: Arcus Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcus Biosciences's interest coverage.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcus Biosciences's interest coverage?
- Arcus Biosciences (RCUS) reported interest coverage of -39.8× in Q1 2026.
- How has Arcus Biosciences's interest coverage changed year-over-year?
- Arcus Biosciences's interest coverage increased by 63.5% year-over-year, from -109× to -39.8×.
- What is the long-term trend for Arcus Biosciences's interest coverage?
- Over 2 years (2022 to 2025), Arcus Biosciences's interest coverage has grown at a -41.3% compound annual growth rate (CAGR), from -140× to -48.3×.
- What does interest coverage mean?
- Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.